Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical trials and approvals for novel biomedicines, escalating healthcare spending, and favorable reimbursement policies.
Highlighted with 41 tables and 85 figures, this 159-page report “Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
o Granulocyte Colony Stimulating Factor
o P53 Protein
o P38 Protein
o Other Purified Proteins
o Amyloid Protein
o Defensin
o Transferrin
o Recombinant Insulin
o Other Recombinant Hormones
? Cancer Vaccines
? Malaria Vaccines
? Ebola Vaccines
? Hepatitis Vaccines
? Tetanus Vaccines
? Diphtheria Vaccines
? Cholera Vaccines
? Other Recombinant Vaccines
o Conventional Vaccines
? Polio Vaccines
? Pox Vaccines
? Other Conventional Vaccines
o Cyclase
o Caspase
o Cathepsin
o Autologous Products
o Acellular Products
o Other Products
Based on Testing Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
Highlighted with 41 tables and 85 figures, this 159-page report “Asia Pacific Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Monoclonal Antibodies
o Anti-inflammatory Monoclonal Antibodies
o Other Monoclonal Antibodies
- Recombinant Growth Factors
o Granulocyte Colony Stimulating Factor
- Purified Proteins
o P53 Protein
o P38 Protein
o Other Purified Proteins
- Recombinant Proteins
o Amyloid Protein
o Defensin
o Transferrin
- Recombinant Hormones
o Recombinant Insulin
o Other Recombinant Hormones
- Vaccines
? Cancer Vaccines
? Malaria Vaccines
? Ebola Vaccines
? Hepatitis Vaccines
? Tetanus Vaccines
? Diphtheria Vaccines
? Cholera Vaccines
? Other Recombinant Vaccines
o Conventional Vaccines
? Polio Vaccines
? Pox Vaccines
? Other Conventional Vaccines
- Recombinant Enzymes
o Cyclase
o Caspase
o Cathepsin
- Cell and Gene Therapies
o Autologous Products
o Acellular Products
- Synthetic Immunomodulators
- Other Product Types
o Other Products
Based on Testing Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
- Laboratory Testing
- Custom Testing/Customer Proprietary Testing
- Compendial and Multi Compendial Laboratory Testing
- Formulation Excipients
- Active Pharmaceutical Ingredients (API)
- Other Materials
- Innovative Biopharmaceuticals
- Biogenerics and Biosimilars
- Oncology
- Inflammatory and Infectious Diseases
- Autoimmune Disorders
- Metabolic Disorders
- Hormonal Disorders
- Cardiovascular Diseases
- Neurological Diseases
- Other Therapeutic Areas
- Japan
- China
- South Korea
- Australia
- India
- Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT TYPE
3.1 Market Overview by Product Type
3.2 Monoclonal Antibodies
3.2.1 Anti-cancer Monoclonal Antibodies
3.2.2 Anti-inflammatory Monoclonal Antibodies
3.2.3 Other Monoclonal Antibodies
3.3 Recombinant Growth Factors
3.3.1 Erythropoietin
3.3.2 Granulocyte Colony Stimulating Factor
3.4 Purified Proteins
3.4.1 Leukemia Inhibitory Factor (LIF)
3.4.2 P53 Protein
3.4.3 P38 Protein
3.4.4 Other Purified Proteins
3.5 Recombinant Proteins
3.5.1 Serum Albumin
3.5.2 Amyloid Protein
3.5.3 Defensin
3.5.4 Transferrin
3.6 Recombinant Hormones
3.6.1 Recombinant Human Growth Hormones
3.6.2 Recombinant Insulin
3.6.3 Other Recombinant Hormones
3.7 Vaccines
3.7.1 Recombinant Vaccines
3.7.2 Conventional Vaccines
3.8 Recombinant Enzymes
3.8.1 Enterokinase
3.8.2 Cyclase
3.8.3 Caspase
3.8.4 Cathepsin
3.9 Cell and Gene Therapies
3.9.1 Allogenic Products
3.9.2 Autologous Products
3.9.3 Acellular Products
3.10 Synthetic Immunomodulators
3.11 Other Product Types
3.11.1 Blood Factors
3.11.2 Other Products
4 SEGMENTATION OF ASIA PACIFIC MARKET BY TESTING SERVICE
4.1 Market Overview by Testing Service
4.2 Laboratory Testing
4.3 Custom Testing/Customer Proprietary Testing
4.4 Compendial and Multi Compendial Laboratory Testing
5 SEGMENTATION OF ASIA PACIFIC MARKET BY RAW MATERIAL
5.1 Market Overview by Raw Material
5.2 Formulation Excipients
5.3 Active Pharmaceutical Ingredients (API)
5.4 Other Materials
6 SEGMENTATION OF ASIA PACIFIC MARKET BY CLASSIFICATION
6.1 Market Overview by Classification
6.2 Innovative Biopharmaceuticals
6.3 Biogenerics and Biosimilars
7 SEGMENTATION OF ASIA PACIFIC MARKET BY THERAPEUTIC AREA
7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Inflammatory and Infectious Diseases
7.4 Autoimmune Disorders
7.5 Metabolic Disorders
7.6 Hormonal Disorders
7.7 Cardiovascular Diseases
7.8 Neurological Diseases
7.9 Other Therapeutic Areas
8 ASIA-PACIFIC MARKET 2023-2033 BY COUNTRY
8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict
2.1.4 Impact of Israel-Palestine War
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT TYPE
3.1 Market Overview by Product Type
3.2 Monoclonal Antibodies
3.2.1 Anti-cancer Monoclonal Antibodies
3.2.2 Anti-inflammatory Monoclonal Antibodies
3.2.3 Other Monoclonal Antibodies
3.3 Recombinant Growth Factors
3.3.1 Erythropoietin
3.3.2 Granulocyte Colony Stimulating Factor
3.4 Purified Proteins
3.4.1 Leukemia Inhibitory Factor (LIF)
3.4.2 P53 Protein
3.4.3 P38 Protein
3.4.4 Other Purified Proteins
3.5 Recombinant Proteins
3.5.1 Serum Albumin
3.5.2 Amyloid Protein
3.5.3 Defensin
3.5.4 Transferrin
3.6 Recombinant Hormones
3.6.1 Recombinant Human Growth Hormones
3.6.2 Recombinant Insulin
3.6.3 Other Recombinant Hormones
3.7 Vaccines
3.7.1 Recombinant Vaccines
3.7.2 Conventional Vaccines
3.8 Recombinant Enzymes
3.8.1 Enterokinase
3.8.2 Cyclase
3.8.3 Caspase
3.8.4 Cathepsin
3.9 Cell and Gene Therapies
3.9.1 Allogenic Products
3.9.2 Autologous Products
3.9.3 Acellular Products
3.10 Synthetic Immunomodulators
3.11 Other Product Types
3.11.1 Blood Factors
3.11.2 Other Products
4 SEGMENTATION OF ASIA PACIFIC MARKET BY TESTING SERVICE
4.1 Market Overview by Testing Service
4.2 Laboratory Testing
4.3 Custom Testing/Customer Proprietary Testing
4.4 Compendial and Multi Compendial Laboratory Testing
5 SEGMENTATION OF ASIA PACIFIC MARKET BY RAW MATERIAL
5.1 Market Overview by Raw Material
5.2 Formulation Excipients
5.3 Active Pharmaceutical Ingredients (API)
5.4 Other Materials
6 SEGMENTATION OF ASIA PACIFIC MARKET BY CLASSIFICATION
6.1 Market Overview by Classification
6.2 Innovative Biopharmaceuticals
6.3 Biogenerics and Biosimilars
7 SEGMENTATION OF ASIA PACIFIC MARKET BY THERAPEUTIC AREA
7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Inflammatory and Infectious Diseases
7.4 Autoimmune Disorders
7.5 Metabolic Disorders
7.6 Hormonal Disorders
7.7 Cardiovascular Diseases
7.8 Neurological Diseases
7.9 Other Therapeutic Areas
8 ASIA-PACIFIC MARKET 2023-2033 BY COUNTRY
8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott Laboratories
Amgen Inc.
Astrazeneca PLC
Bayer AG
Biogen Inc.
Bristol-myers Squibb Company (BMS)
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Glaxosmithkline PLC
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Novo Nordisk As
Pfizer Inc.
Sanofi Sa
Sharp Packaging Services
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals
WuXi AppTec
RELATED REPORTS
LIST OF TABLES
Table 1. Snapshot of Asia Pacific Biopharmaceuticals Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 8. Worldwide Number of New Cancer by Type, 2020
Table 9. Main Product Trends and Market Opportunities in Asia Pacific Biopharmaceuticals Market
Table 10. Asia Pacific Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 11. Asia Pacific Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn
Table 12. Asia Pacific Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn
Table 13. Asia Pacific Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn
Table 14. Asia Pacific Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn
Table 15. Asia Pacific Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022
Table 17. Asia Pacific Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn
Table 18. Asia Pacific Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn
Table 19. Asia Pacific Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn
Table 20. Asia Pacific Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn
Table 21. Asia Pacific Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn
Table 22. Asia Pacific Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn
Table 23. Asia Pacific Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn
Table 24. Asia Pacific Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn
Table 25. Asia Pacific Biopharmaceuticals Market by Classification, 2023-2033, $ mn
Table 26. Asia Pacific Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 27. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 28. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 29. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 30. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 31. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 32. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 33. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 34. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 35. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 36. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 37. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 38. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 39. Abbott Laboratories: Company Snapshot
Table 40. Abbott Laboratories: Business Segmentation
Table 41. Abbott Laboratories: Product Portfolio
Table 1. Snapshot of Asia Pacific Biopharmaceuticals Market in Balanced Perspective, 2023-2033
Table 2. World Economic Outlook, 2024-2036
Table 3. World Economic Outlook, 2022-2024
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. Scenarios for Economic Impact of Israel-Palestine War
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 8. Worldwide Number of New Cancer by Type, 2020
Table 9. Main Product Trends and Market Opportunities in Asia Pacific Biopharmaceuticals Market
Table 10. Asia Pacific Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 11. Asia Pacific Biopharmaceuticals Market: Monoclonal Antibodies by Type, 2023-2033, $ mn
Table 12. Asia Pacific Biopharmaceuticals Market: Recombinant Growth Factor by Type, 2023-2033, $ mn
Table 13. Asia Pacific Biopharmaceuticals Market: Purified Proteins by Type, 2023-2033, $ mn
Table 14. Asia Pacific Biopharmaceuticals Market: Recombinant Proteins by Type, 2023-2033, $ mn
Table 15. Asia Pacific Biopharmaceuticals Market: Recombinant Hormones by Type, 2023-2033, $ mn
Table 16. Selected Drugs for COVID-19 Treatment in Development, Nov 2022
Table 17. Asia Pacific Biopharmaceuticals Market: Vaccines by Type, 2023-2033, $ mn
Table 18. Asia Pacific Biopharmaceuticals Market: Recombinant Vaccines by Type, 2023-2033, $ mn
Table 19. Asia Pacific Biopharmaceuticals Market: Conventional Vaccines by Type, 2023-2033, $ mn
Table 20. Asia Pacific Biopharmaceuticals Market: Recombinant Enzymes by Type, 2023-2033, $ mn
Table 21. Asia Pacific Biopharmaceuticals Market: Cell and Gene Therapies by Type, 2023-2033, $ mn
Table 22. Asia Pacific Biopharmaceuticals Market: Other Product Types by Type, 2023-2033, $ mn
Table 23. Asia Pacific Biopharmaceuticals Market by Testing Service, 2023-2033, $ mn
Table 24. Asia Pacific Biopharmaceuticals Market by Raw Material, 2023-2033, $ mn
Table 25. Asia Pacific Biopharmaceuticals Market by Classification, 2023-2033, $ mn
Table 26. Asia Pacific Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 27. APAC Biopharmaceuticals Market by Country, 2023-2033, $ mn
Table 28. Japan Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 29. Japan Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 30. China Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 31. China Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 32. Australia Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 33. Australia Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 34. India Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 35. India Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 36. South Korea Biopharmaceuticals Market by Product Type, 2023-2033, $ mn
Table 37. South Korea Biopharmaceuticals Market by Therapeutic Area, 2023-2033, $ mn
Table 38. Biopharmaceuticals Market in Rest of APAC by Country/Region, 2023-2033, $ mn
Table 39. Abbott Laboratories: Company Snapshot
Table 40. Abbott Laboratories: Business Segmentation
Table 41. Abbott Laboratories: Product Portfolio
LIST OF FIGURES
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Asia Pacific Biopharmaceuticals Market, 2023-2033, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biopharmaceuticals Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Biopharmaceuticals Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Biopharmaceuticals Market
Figure 13. Breakdown of Asia Pacific Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn
Figure 16. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn
Figure 17. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn
Figure 18. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn
Figure 19. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn
Figure 20. Asia Pacific Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn
Figure 21. Asia Pacific Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn
Figure 22. Asia Pacific Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn
Figure 23. Asia Pacific Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn
Figure 24. Asia Pacific Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn
Figure 25. Asia Pacific Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn
Figure 26. Asia Pacific Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn
Figure 27. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn
Figure 28. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn
Figure 29. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn
Figure 30. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn
Figure 31. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn
Figure 32. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn
Figure 33. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn
Figure 34. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn
Figure 35. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn
Figure 36. Asia Pacific Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn
Figure 37. Asia Pacific Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn
Figure 38. Asia Pacific Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn
Figure 39. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn
Figure 40. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn
Figure 41. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn
Figure 42. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn
Figure 43. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn
Figure 44. Asia Pacific Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn
Figure 45. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn
Figure 46. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn
Figure 47. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn
Figure 48. Asia Pacific Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn
Figure 49. Asia Pacific Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn
Figure 50. Asia Pacific Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn
Figure 51. Asia Pacific Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn
Figure 52. Breakdown of Asia Pacific Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue
Figure 53. Asia Pacific Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%)
Figure 54. Asia Pacific Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn
Figure 55. Asia Pacific Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn
Figure 56. Asia Pacific Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn
Figure 57. Breakdown of Asia Pacific Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue
Figure 58. Asia Pacific Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%)
Figure 59. Asia Pacific Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn
Figure 60. Asia Pacific Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn
Figure 61. Asia Pacific Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn
Figure 62. Breakdown of Asia Pacific Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue
Figure 63. Asia Pacific Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%)
Figure 64. Asia Pacific Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn
Figure 65. Asia Pacific Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn
Figure 66. Breakdown of Asia Pacific Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue
Figure 67. Asia Pacific Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 68. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn
Figure 69. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn
Figure 70. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn
Figure 71. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn
Figure 72. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn
Figure 73. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn
Figure 74. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn
Figure 75. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn
Figure 76. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 77. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 78. Biopharmaceuticals Market in Japan, 2023-2033, $ mn
Figure 79. Biopharmaceuticals Market in China, 2023-2033, $ mn
Figure 80. Biopharmaceuticals Market in Australia, 2023-2033, $ mn
Figure 81. Biopharmaceuticals Market in India, 2023-2033, $ mn
Figure 82. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn
Figure 83. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn
Figure 84. Growth Stage of Asia Pacific Biopharmaceuticals Industry over the Forecast Period
Figure 85. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2023-2033
Figure 4. Asia Pacific Biopharmaceuticals Market, 2023-2033, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biopharmaceuticals Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Worldwide Novel Active Substances (NASs) Launches by Therapeutic Area, 2013-2022
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Biopharmaceuticals Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Biopharmaceuticals Market
Figure 13. Breakdown of Asia Pacific Biopharmaceuticals Market by Product Type, 2023-2033, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2024-2033 by Product Type, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Biopharmaceuticals Market by Product Type: Monoclonal Antibodies, 2023-2033, $ mn
Figure 16. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Anti-cancer Monoclonal Antibodies, 2023-2033, $ mn
Figure 17. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Anti-inflammatory Monoclonal Antibodies, 2023-2033, $ mn
Figure 18. Asia Pacific Biopharmaceuticals Market by Monoclonal Antibodies: Other Monoclonal Antibodies, 2023-2033, $ mn
Figure 19. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Growth Factors, 2023-2033, $ mn
Figure 20. Asia Pacific Biopharmaceuticals Market by Recombinant Growth Factor: Erythropoietin, 2023-2033, $ mn
Figure 21. Asia Pacific Biopharmaceuticals Market by Recombinant Growth Factor: Granulocyte Colony Stimulating Factor, 2023-2033, $ mn
Figure 22. Asia Pacific Biopharmaceuticals Market by Product Type: Purified Proteins, 2023-2033, $ mn
Figure 23. Asia Pacific Biopharmaceuticals Market by Purified Proteins: Leukemia Inhibitory Factor (LIF), 2023-2033, $ mn
Figure 24. Asia Pacific Biopharmaceuticals Market by Purified Proteins: P53 Protein, 2023-2033, $ mn
Figure 25. Asia Pacific Biopharmaceuticals Market by Purified Proteins: P38 Protein, 2023-2033, $ mn
Figure 26. Asia Pacific Biopharmaceuticals Market by Purified Proteins: Other Purified Proteins, 2023-2033, $ mn
Figure 27. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Proteins, 2023-2033, $ mn
Figure 28. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Serum Albumin, 2023-2033, $ mn
Figure 29. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Amyloid Protein, 2023-2033, $ mn
Figure 30. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Defensin, 2023-2033, $ mn
Figure 31. Asia Pacific Biopharmaceuticals Market by Recombinant Proteins: Transferrin, 2023-2033, $ mn
Figure 32. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Hormones, 2023-2033, $ mn
Figure 33. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Recombinant Human Growth Hormones, 2023-2033, $ mn
Figure 34. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Recombinant Insulin, 2023-2033, $ mn
Figure 35. Asia Pacific Biopharmaceuticals Market by Recombinant Hormones: Other Recombinant Hormones, 2023-2033, $ mn
Figure 36. Asia Pacific Biopharmaceuticals Market by Product Type: Vaccines, 2023-2033, $ mn
Figure 37. Asia Pacific Biopharmaceuticals Market by Vaccines: Recombinant Vaccines, 2023-2033, $ mn
Figure 38. Asia Pacific Biopharmaceuticals Market by Vaccines: Conventional Vaccines, 2023-2033, $ mn
Figure 39. Asia Pacific Biopharmaceuticals Market by Product Type: Recombinant Enzymes, 2023-2033, $ mn
Figure 40. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Enterokinase, 2023-2033, $ mn
Figure 41. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Cyclase, 2023-2033, $ mn
Figure 42. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Caspase, 2023-2033, $ mn
Figure 43. Asia Pacific Biopharmaceuticals Market by Recombinant Enzymes: Cathepsin, 2023-2033, $ mn
Figure 44. Asia Pacific Biopharmaceuticals Market by Product Type: Cell and Gene Therapies, 2023-2033, $ mn
Figure 45. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Allogenic Products, 2023-2033, $ mn
Figure 46. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Autologous Products, 2023-2033, $ mn
Figure 47. Asia Pacific Biopharmaceuticals Market by Cell and Gene Therapies: Acellular Products, 2023-2033, $ mn
Figure 48. Asia Pacific Biopharmaceuticals Market by Product Type: Synthetic Immunomodulators, 2023-2033, $ mn
Figure 49. Asia Pacific Biopharmaceuticals Market by Product Type: Other Product Types, 2023-2033, $ mn
Figure 50. Asia Pacific Biopharmaceuticals Market by Other Product Types: Blood Factors, 2023-2033, $ mn
Figure 51. Asia Pacific Biopharmaceuticals Market by Other Product Types: Other Products, 2023-2033, $ mn
Figure 52. Breakdown of Asia Pacific Biopharmaceuticals Market by Testing Service, 2023-2033, % of Sales Revenue
Figure 53. Asia Pacific Addressable Market Cap in 2024-2033 by Testing Service, Value ($ mn) and Share (%)
Figure 54. Asia Pacific Biopharmaceuticals Market by Testing Service: Laboratory Testing, 2023-2033, $ mn
Figure 55. Asia Pacific Biopharmaceuticals Market by Testing Service: Custom Testing/Customer Proprietary Testing, 2023-2033, $ mn
Figure 56. Asia Pacific Biopharmaceuticals Market by Testing Service: Compendial and Multi Compendial Laboratory Testing, 2023-2033, $ mn
Figure 57. Breakdown of Asia Pacific Biopharmaceuticals Market by Raw Material, 2023-2033, % of Sales Revenue
Figure 58. Asia Pacific Addressable Market Cap in 2024-2033 by Raw Material, Value ($ mn) and Share (%)
Figure 59. Asia Pacific Biopharmaceuticals Market by Raw Material: Formulation Excipients, 2023-2033, $ mn
Figure 60. Asia Pacific Biopharmaceuticals Market by Raw Material: Active Pharmaceutical Ingredients (API), 2023-2033, $ mn
Figure 61. Asia Pacific Biopharmaceuticals Market by Raw Material: Other Materials, 2023-2033, $ mn
Figure 62. Breakdown of Asia Pacific Biopharmaceuticals Market by Classification, 2023-2033, % of Revenue
Figure 63. Asia Pacific Addressable Market Cap in 2024-2033 by Classification, Value ($ mn) and Share (%)
Figure 64. Asia Pacific Biopharmaceuticals Market by Classification: Innovative Biopharmaceuticals, 2023-2033, $ mn
Figure 65. Asia Pacific Biopharmaceuticals Market by Classification: Biogenerics and Biosimilars, 2023-2033, $ mn
Figure 66. Breakdown of Asia Pacific Biopharmaceuticals Market by Therapeutic Area, 2023-2033, % of Revenue
Figure 67. Asia Pacific Addressable Market Cap in 2024-2033 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 68. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Oncology, 2023-2033, $ mn
Figure 69. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Inflammatory and Infectious Diseases, 2023-2033, $ mn
Figure 70. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Autoimmune Disorders, 2023-2033, $ mn
Figure 71. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Metabolic Disorders, 2023-2033, $ mn
Figure 72. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Hormonal Disorders, 2023-2033, $ mn
Figure 73. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Cardiovascular Diseases, 2023-2033, $ mn
Figure 74. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Neurological Diseases, 2023-2033, $ mn
Figure 75. Asia Pacific Biopharmaceuticals Market by Therapeutic Area: Other Therapeutic Areas, 2023-2033, $ mn
Figure 76. Breakdown of APAC Biopharmaceuticals Market by Country, 2023 and 2033, % of Revenue
Figure 77. Contribution to APAC 2024-2033 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 78. Biopharmaceuticals Market in Japan, 2023-2033, $ mn
Figure 79. Biopharmaceuticals Market in China, 2023-2033, $ mn
Figure 80. Biopharmaceuticals Market in Australia, 2023-2033, $ mn
Figure 81. Biopharmaceuticals Market in India, 2023-2033, $ mn
Figure 82. Biopharmaceuticals Market in South Korea, 2023-2033, $ mn
Figure 83. Biopharmaceuticals Market in Rest of APAC, 2023-2033, $ mn
Figure 84. Growth Stage of Asia Pacific Biopharmaceuticals Industry over the Forecast Period
Figure 85. Worldwide Top Ten Best-selling Biotech Drugs in 2022, $ bn
